Trials / Withdrawn
WithdrawnNCT00893048
The Use of Oral Steroids in the Treatment of Cellulitis
Utility of Prednisone in the Treatment of Cellulitis
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Milton S. Hershey Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The prevalence of cellulitis in society is very high, as much as 3% of visits to Emergency Departments are for the treatment of this disease. The treatment of cellulitis varies depending on the severity. Low severity cases are treated with pain control and antibiotics by mouth and high severity are treated with antibiotics intravenously and pain control. The investigator's hypothesis is to see if the addition of steroids, which are known to decrease inflammation, will decrease the length of the disease process. If so, it will decrease the length of stay if IV antibiotics are needed, it will decrease duration of days out of work and decrease the overall pain control required and therefore patient satisfaction.
Detailed description
The incidence of cellulitis is about 24.6 cases per 1000 person-years, which is an estimate, since cellulitis is not a reportable disease. In some Emergency Departments up to 3% of visits are for cellulitis. Depending on the severity of the disease, some are treated as outpatients, and others are admitted for IV antibiotics. In some Emergency Departments cases of cellulitis are treated in an observation area for 23 hours with doses of IV antibiotics. My proposed research is to see if the addition of one dose of prednisone the treatment will decrease the inflammatory reaction enough to decrease length of stay and treatment and increase patient satisfaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prednisone | Prednisone, 60 mg, one time at time of diagnosis |
| DRUG | Placebo Oral Tablet | Placebo |
Timeline
- Start date
- 2010-01-15
- Primary completion
- 2010-08-31
- Completion
- 2010-08-31
- First posted
- 2009-05-05
- Last updated
- 2017-07-25
Source: ClinicalTrials.gov record NCT00893048. Inclusion in this directory is not an endorsement.